Skip to content
Screener

Johnson & Johnson JNJ SPRAVATO — Percent Change (as a percent)

Similar metrics at other companies

Healthcare Services Group logo
HCSGPercent of liabilities (as a percent)
24.8%-0.6pp
Calix logo
CALXPercent of historical volatility (as a percent)
50%0.0pp
Calix logo
CALXPercent of implied volatility (as a percent)
50%0.0pp
Equifax logo
EFXVerification Services — Change in revenue (as a percent)
7%-3.0pp
Equifax logo
EFXEmployer Services — Change in revenue (as a percent)
3%+2.1pp
Equifax logo
EFXEurope — Change in revenue (as a percent)
2%-10.0pp

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$620.77B+51.1%
Enterprise value$649.38B+46.6%
P/E29.5×+11.4×
P/S6.3×+1.8×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept jnj:PercentageChangeInSalesBySegmentOfBusiness.

The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000200406-26-000153
(Dollars in Millions)Fiscal Second Quarter Ended / June 28,2026Fiscal Second Quarter Ended / June 29,2025Fiscal Second Quarter Ended / Percent ChangeFiscal Six Months Ended / June 28,2026Fiscal Six Months Ended / June 29,2025Fiscal Six Months Ended / Percent Change
SPRAVATO
U.S.51436640.792064243.4
International705041.21319341.8
Worldwide58441440.81,05273443.2
CAPLYTA(2)
U.S.36121170.9631211*
International——————
Worldwide36121170.9631211*

Item 1 — Financial statements

FAQ

What is Johnson & Johnson's SPRAVATO — percent change (as a percent)?
Johnson & Johnson (JNJ) reported SPRAVATO — percent change (as a percent) of 40.8% in Q2 2026.
How has Johnson & Johnson's SPRAVATO — percent change (as a percent) changed year-over-year?
Johnson & Johnson's SPRAVATO — percent change (as a percent) decreased by 23.5% year-over-year, from 53.3% to 40.8%.
What does SPRAVATO — percent change (as a percent) mean?
This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It provides a normalized view of the product's commercial momentum, stripping away absolute scale to highlight the velocity of market penetration or decline. Investors use this to evaluate the product's trajectory relative to historical performance and broader market trends.

Ask your AI about Johnson & Johnson's spravato — percent change (as a percent).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude